傳百度(09888.HK)旗下集度汽車與禾賽科技簽約
有內媒引述消息報道,指百度(09888.HK)旗下智能造車公司集度汽車即將和國內激光公司禾賽科技合作。而百度和集度未有回應。
報道指,百度自身的自動駕駛路線是以攝像頭、高精地圖為核心的「純視覺」技術路線,而非禾賽科技的激光雷達路線。因此值得關注集度未來將採用哪種技術方案。
據天眼查APP顯示,上海禾賽科技有限公司成立於2014年,公司主營業務為自動駕駛激光雷達,並且在2018年獲得過由百度領投的B輪融資2.5億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.